期刊文献+

血清半胱氨酸蛋白酶抑制物C与急性心肌梗死泵衰竭和近期预后的相关性 被引量:3

Correlation of serum cystatin C and pump failure and short-term prognosis of patients with acute myocardial infarction
原文传递
导出
摘要 目的研究血清半胱氨酸蛋白酶抑制物C(CysC)与急性心肌梗死(AMI)泵衰竭及近期预后的相关性。方法 AMI患者184例,根据入院后24h内血清CysC的水平分为两组:A组102例,血清CysC为(1.95±0.40)mg/L;B组82例,血清CysC为(1.20±0.20)mg/L。比较两组心功能Killip分级和3个月内病死率,分析血清CysC水平对AMI泵衰竭及近期预后的影响。结果 A组血清CysC水平、Killip分级和近期病死率均高于B组(P<0.05或P<0.01)。生存病例3个月随访期间,A组心血管事件发生率27.7%(23/83),高于B组的13.2%(10/76)(P<0.01)。Logistic回归分析表明,年龄、血清CsyC水平、心功能Killip分级和高血压病为AMI患者住院病死率的相关危险因素(P<0.05或P<0.01);而血清CsyC水平和心功能Killip分级是影响AMI患者3个月内发生严重心血管事件的独立因素(P<0.01)。结论 CysC可能作为AMI患者泵衰竭及近期预后的独立危险因素。 [Abstract] Objective To investigate the correlation of serum cystatin C(CysC) and pump failure and short-term prognosis of patients with acute myocardial infarction(AMI). Methods On the basis of serum level of CysC, 184 patients with AMI were devided into two groups of A[CysC (1.95±0. 40) mg/L, 102 cases] and B[CysC (1.20±0. 20) mg/L,82 cases]. The grades of Killip and hospital mortality in three months were compared between two groups. The effects of serum level of CysC on the pump failure and short-term prognosis were analyzed. Results Serum level of CysC, Killip grade and death rates in three months were higher in group A than those in group B(P〈0. 05 or P〈0. 01). The incidence rate of serious cardiovascular events during 3 months follow-up in the survivals was higher in group A than that in group B1-27. 7% (23/83) vs. 13. 2% (10/76)] (P〈0. 01). Logistic regression analysis showed that elder age, serum level of CysC, Killip grade and hypertention were the risk factors for the mortality in hosipital(P〈0. 05 or P〈0. 01). Serum level of CsyC and Killip grade were the independent risk factors for serious cardiovascular events in short-term (P〈0. 01 ). Conclusion Serum level of CysC could be an independent risk factor for the pump failure and short- term prognosis in the patients with AMI.
出处 《江苏医药》 CAS 北大核心 2014年第15期1783-1785,共3页 Jiangsu Medical Journal
关键词 半胱氨酸蛋白酶抑制物C 急性心肌梗死 泵衰竭 Cystatin C Acute myocardial infarction Pump failure
  • 相关文献

参考文献7

  • 1孙世荣,董强.肾病综合征患者血清胱抑素C检测的临床意义[J].中国老年学杂志,2009,29(14):1830-1831. 被引量:16
  • 2Shlipak MG, Katz R, Kestenbaum B, et al. Clinical and subclini- cal cardiovascular disease and kidney function decline in the elderly[J]. Atherosclerosis, 2009,204 (1) : 298-303.
  • 3Kiyosue A, Hirata Y, Ando J, et al. Plasma cystain C concen- tration reflects the severity of coronary atery disease in patients whitout chronic kidney desease[J]. Circ J, 2010, 74(11):2441- 2447.
  • 4Derzhko R, Plaksej R, Przewlocka-Kosmala M, et al. Prediction of left ventricular dysfunction progression in patients with a first ST-elevation myocardial infarctiomcontribution of csytain C assessment[J]. Coron Artery Dis,2009,20(7):453-461.
  • 5王超权,徐耕,程刚.血清胱抑素C水平对缺血性心力衰竭患者近期预后的影响[J].中国循环杂志,2009,24(1):28-31. 被引量:49
  • 6Windhausen F, Hirseh A, Fischer J. Cystain C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponion T [J]. Clin Chem, 2009,55(6) : 1118-1125.
  • 7宗文仓,孔令军,冯晓云,刘丽霞,刘淑红,王继清,安国辉.血清胱抑素C水平对急性心肌梗死患者急性期预后的影响[J].临床荟萃,2011,26(11):961-962. 被引量:9

二级参考文献26

  • 1方一卿,马骏,沈汉超,鲁盈.血清胱抑素C评价慢性肾脏病患者早期肾损害的临床研究[J].中国中西医结合肾病杂志,2007,8(3):145-148. 被引量:58
  • 2Filler G,Bokenkamp A,Hofmann W,et al.Cystatin C as a marker of GFR history,Indications and future research[J].Clin Biochem,2005,38(1):1-8.
  • 3Sarnak MJ,Katz R,Stehman-Breon CO,et al.Cystatin C concentration as a risk factor for heart failure in older adults.Ann Intern Med,2005,142(7):497-505.
  • 4陈灏珠译.心脏病学[M].第5版.北京:人民卫生出版社,2003.407-411.
  • 5Barka T,van der Noon H.Expression of the cysteine proteinase inhibitor Cystatin C gene in rat heart:use of digoxi-genin-labeled probes generated by polymerase chain reaction directly for in situ and northem blot hybridizations.J Histochem Cytochem,1993,41:1863-1867.
  • 6Bostom AG,Bausserman L,Jacques PF,et al.Cystatin C as a determinant of fasting plasma total homocysteine levels in coronary artery disease patients with normal serum creatinine.Arterioscler Thromb Vasc Biol,1999,19:2241-2244.
  • 7Sc hiffrin EL,Lipman ML,Mann JF.Chronic kidney disease:effects on the cardiovascular system.Circulation,2007,116:85-97.
  • 8Lassus J,Harjola VP,Sund R,et al.Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP.Eur Heart J,2007,28(15):1841-1847.
  • 9Ix JH,Shlipak MG,Chertow GM,et al.Association of cystatin C with mortality,cardiovascular events,and incident heart failure among persons with coronary heart disease:data from the Heart and Soul Study.Circulation,2007,115:173-179.
  • 10Tan GD,LewisAV,James TJ,et al.Clinical usefulness of Cystasin C for the estimation of glornendar mate in type 1 diabetes[J].Diabetes Care,2002;25(11):2004-9.

共引文献69

同被引文献29

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部